Form 4: Astera Labs COO Sells $47M in Shares

Astera Labs' President and COO, Sanjay Gajendra, sold 279,963 shares of common stock for approximately $47.3 million through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Sanjay Gajendra, President and COO, and a Director of Astera Labs, Inc. (ALAB), sold 279,963 shares of common stock on August 7, 2025.
• The sales were executed at weighted average prices ranging from $165.7531 to $174.8869 per share.
• The total value of shares sold is approximately $47.3 million.
• These transactions were conducted automatically under a Rule 10b5-1 trading plan adopted on November 30, 2024.
• Following these sales, Gajendra's beneficial ownership includes 5,525,545 shares held indirectly by Trust 1, 695,000 shares by Trust 2, 695,000 shares by Trust 3, and 2,262,318 shares held directly, totaling 9,177,863 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the fact that it was conducted under a pre-arranged Rule 10b5-1 plan mitigates concerns, indicating a planned liquidity event rather than a reaction to adverse company news.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new negative information.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the insider's direct stake in the company.

Future Outlook

NA

Industry Context

This Form 4 filing reports an insider stock sale, which is a routine disclosure for publicly traded companies. It does not provide specific insights into broader industry trends or competitive landscape beyond the fact that a key executive at a data center connectivity company is managing personal liquidity.

Related Party Transactions

• Sales of shares were made from holdings indirectly owned by estate planning trusts (Trust 1, Trust 2, Trust 3) where the reporting person is a trustee or has a pecuniary interest.

Stakeholder Impact

• Shareholders may observe a reduction in direct insider ownership, though the pre-arranged nature of the sale under a 10b5-1 plan typically lessens concerns about management's confidence in the company's future.

Key Dates

Recommendation

The filing details a pre-planned insider stock sale via a Rule 10b5-1 plan, which is a routine event for executives managing personal finances. It does not indicate any new material information about Astera Labs' operational performance or future prospects. Therefore, the filing itself does not provide a basis for a change in investment recommendation; a 'hold' stance is maintained, pending further fundamental analysis of the company's business.

Keywords

Astera Labs, ALAB, Sanjay Gajendra, Insider Selling, Form 4, Rule 10b5-1, Stock Sale, Corporate Officer, Semiconductor, Data Center Connectivity